Objective: Combined hyperlipidaemia is a common and highly atherogenic lipid phenotype with multiple lipoprotein abnormalities that are difficult to normalise with single-drug therapy. The ATOMIX ...

Description: The goal of the trial was to evaluate the effect of intensive lipid-lowering therapy with atorvastatin compared with placebo among patients with prior stroke or transient ischemic ...